Personal information

No personal information available

Activities

Works (6)

Rational Engineering of Escherichia coli Nissle 1917 as Live Biotherapeutic to Degrade Uremic Toxin Precursors

ACS Synthetic Biology
2024-04-19 | Journal article
Contributors: David Lubkowicz; David L. Hava; Kim Lewis; Vincent M. Isabella
Source: check_circle
Crossref

An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and <i>in silico</i> simulations of enteric hyperoxaluria

Molecular Systems Biology
2022-03 | Journal article
Part of ISSN: 1744-4292
Part of ISSN: 1744-4292
Source: Self-asserted source
David Lubkowicz
grade
Preferred source (of 2)‎

Characterization of an engineered live bacterial therapeutic for the treatment of phenylketonuria in a human gut-on-a-chip

Nature Communications
2021-12 | Journal article
Part of ISSN: 2041-1723
Source: Self-asserted source
David Lubkowicz

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Nature Biotechnology
2018-10 | Journal article
Part of ISSN: 1087-0156
Part of ISSN: 1546-1696
Source: Self-asserted source
David Lubkowicz

Reprogramming Probiotic Lactobacillus reuteri as a Biosensor for Staphylococcus aureus Derived AIP-I Detection

ACS Synthetic Biology
2018-05-18 | Journal article
Part of ISSN: 2161-5063
Part of ISSN: 2161-5063
Source: Self-asserted source
David Lubkowicz

Transplantability of a circadian clock to a noncircadian organism

Science Advances
2015-06-05 | Journal article
Part of ISSN: 2375-2548
Source: Self-asserted source
David Lubkowicz